Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Chest Imaging, Breath, and Biomarkers in a Screening Trial


A Clinical Trial to Develop Chest Imaging, Breath, and Biomarkers in a Screening Trial




The investigators would like to see if lung cancer screening with chest x-rays,computer aided detection (CAD)and a lose dose CT scan can detect lung cancer in early stages when it is more responsive to treatment. The investigators would also like to see if early detection will reduce the incidence of symptomatic advanced lung cancer compared to no screening in former and current smokers with or without a family history of lung cancer who are 40-75 years old.

Study Status: Active, not recruiting


Condition Intervention Phase
Lung Cancer Device: chest x-ray with or without CAD, lose dose CT scan N/A

Verified by The Cleveland Clinic August, 2012

Sponsored by: The Cleveland Clinic
Information provided by: The Cleveland Clinic identifier: NCT01663155

Study Type: Interventional

Study Design: Observational Model: Cohort, Time Perspective: Prospective

Cleveland Clinic
Cleveland, Ohio 44195
United States

Micheal Phillips, M.D.., Study Chair
Moulay Meziane, MD., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit
  Information obtained from on
Link to the current record.

Cleveland Clinic Mobile Site